AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimimak M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Trimak Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimimak M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting sugar source. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimimak M 2mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glimimak M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimimak M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimimak M 2mg/500mg Sustained-Release Tablets should be taken with meals.

Common Side effects of Glimimak M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimimak M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimimak M 2mg/500mg Sustained-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Glimimak M 2mg/500mg Tablet SR works:

Glimimak M 2mg/500mg Extended-Release tablets combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimimak M 2mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimimak M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimimak M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimimak M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimimak M 2mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment with this medication.

LiverLiverCAUTION

Exercise caution when administering Glimimak M 2mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients experiencing mild to moderate liver disease, initiate treatment with a reduced Glimimak M 2mg/500mg Tablet SR dose; this medication is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimimak M 2mg/500mg Tablet SR :

Should you forget a dose of Glimimak M 2mg/500mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimimak M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimimak M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimimak M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. Seek immediate medical attention, including discontinuing Glimimak M, if these symptoms occur.
Glimimak M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glimimak M 2mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Glimimak M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimimak M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimimak M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol may exacerbate the medication's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimimak M 2mg/500mg Tabl...
58
MRP 68
14% off